鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/08 | 4,115 | 4,275 | 4,110 | 4,250 | +135 | +3.3% | 75,800 |
| 2024/11/07 | 4,250 | 4,270 | 4,115 | 4,115 | -85 | -2% | 86,100 |
| 2024/11/06 | 4,175 | 4,325 | 4,175 | 4,200 | +60 | +1.4% | 96,300 |
| 2024/11/05 | 4,250 | 4,250 | 4,070 | 4,140 | -90 | -2.1% | 49,100 |
| 2024/11/01 | 4,075 | 4,280 | 4,045 | 4,230 | +85 | +2.1% | 88,200 |
| 2024/10/31 | 4,100 | 4,160 | 4,060 | 4,145 | +60 | +1.5% | 55,400 |
| 2024/10/30 | 4,015 | 4,150 | 4,015 | 4,085 | +105 | +2.6% | 72,400 |
| 2024/10/29 | 3,825 | 4,050 | 3,825 | 3,980 | +105 | +2.7% | 60,500 |
| 2024/10/28 | 3,855 | 3,940 | 3,795 | 3,875 | +5 | +0.1% | 66,800 |
| 2024/10/25 | 4,090 | 4,090 | 3,860 | 3,870 | -220 | -5.4% | 94,800 |
| 2024/10/24 | 4,110 | 4,145 | 3,965 | 4,090 | -60 | -1.4% | 127,700 |
| 2024/10/23 | 3,920 | 4,180 | 3,920 | 4,150 | +220 | +5.6% | 139,000 |
| 2024/10/22 | 3,920 | 3,940 | 3,915 | 3,930 | -10 | -0.3% | 14,600 |
| 2024/10/21 | 3,915 | 3,945 | 3,910 | 3,940 | +25 | +0.6% | 6,900 |
| 2024/10/18 | 3,920 | 3,950 | 3,915 | 3,915 | ±0 | ±0% | 11,300 |
| 2024/10/17 | 3,905 | 3,935 | 3,905 | 3,915 | +10 | +0.3% | 8,300 |
| 2024/10/16 | 3,860 | 3,935 | 3,860 | 3,905 | +10 | +0.3% | 11,900 |
| 2024/10/15 | 3,940 | 3,940 | 3,885 | 3,895 | ±0 | ±0% | 19,000 |
| 2024/10/11 | 3,940 | 3,940 | 3,870 | 3,895 | -50 | -1.3% | 13,500 |
| 2024/10/10 | 3,925 | 3,945 | 3,890 | 3,945 | +20 | +0.5% | 8,700 |
| 2024/10/09 | 3,890 | 3,930 | 3,890 | 3,925 | +35 | +0.9% | 8,700 |
| 2024/10/08 | 3,905 | 3,950 | 3,885 | 3,890 | -45 | -1.1% | 18,800 |
| 2024/10/07 | 3,940 | 3,960 | 3,910 | 3,935 | +10 | +0.3% | 15,000 |
| 2024/10/04 | 3,960 | 3,965 | 3,925 | 3,925 | -5 | -0.1% | 8,700 |
| 2024/10/03 | 3,930 | 3,960 | 3,885 | 3,930 | +70 | +1.8% | 23,500 |
| 2024/10/02 | 3,880 | 3,920 | 3,845 | 3,860 | -40 | -1% | 39,600 |
| 2024/10/01 | 3,915 | 3,915 | 3,885 | 3,900 | +25 | +0.6% | 13,300 |
| 2024/09/30 | 3,870 | 3,900 | 3,845 | 3,875 | -25 | -0.6% | 24,300 |
| 2024/09/27 | 3,905 | 3,950 | 3,890 | 3,900 | -15 | -0.4% | 25,400 |
| 2024/09/26 | 3,865 | 3,935 | 3,850 | 3,915 | +65 | +1.7% | 39,100 |
| 2024/09/25 | 3,870 | 3,890 | 3,825 | 3,850 | +15 | +0.4% | 40,900 |
| 2024/09/24 | 3,830 | 3,855 | 3,815 | 3,835 | +20 | +0.5% | 17,400 |
| 2024/09/20 | 3,825 | 3,845 | 3,790 | 3,815 | +35 | +0.9% | 24,800 |
| 2024/09/19 | 3,750 | 3,805 | 3,730 | 3,780 | +30 | +0.8% | 16,500 |
| 2024/09/18 | 3,755 | 3,765 | 3,715 | 3,750 | +25 | +0.7% | 15,600 |
| 2024/09/17 | 3,770 | 3,770 | 3,695 | 3,725 | -25 | -0.7% | 30,400 |
| 2024/09/13 | 3,740 | 3,775 | 3,700 | 3,750 | +10 | +0.3% | 28,500 |
| 2024/09/12 | 3,565 | 3,770 | 3,565 | 3,740 | +185 | +5.2% | 58,300 |
| 2024/09/11 | 3,605 | 3,605 | 3,540 | 3,555 | -65 | -1.8% | 34,500 |
| 2024/09/10 | 3,700 | 3,700 | 3,605 | 3,620 | -80 | -2.2% | 21,000 |
| 2024/09/09 | 3,595 | 3,710 | 3,595 | 3,700 | +65 | +1.8% | 26,000 |
| 2024/09/06 | 3,645 | 3,645 | 3,620 | 3,635 | -10 | -0.3% | 13,400 |
| 2024/09/05 | 3,630 | 3,695 | 3,630 | 3,645 | -5 | -0.1% | 18,000 |
| 2024/09/04 | 3,655 | 3,690 | 3,615 | 3,650 | -65 | -1.7% | 19,800 |
| 2024/09/03 | 3,645 | 3,715 | 3,645 | 3,715 | +70 | +1.9% | 28,400 |
| 2024/09/02 | 3,690 | 3,715 | 3,605 | 3,645 | -45 | -1.2% | 19,700 |
| 2024/08/30 | 3,720 | 3,735 | 3,660 | 3,690 | ±0 | ±0% | 43,800 |
| 2024/08/29 | 3,630 | 3,705 | 3,630 | 3,690 | +75 | +2.1% | 23,300 |
| 2024/08/28 | 3,545 | 3,645 | 3,545 | 3,615 | +65 | +1.8% | 24,600 |
| 2024/08/27 | 3,495 | 3,555 | 3,475 | 3,550 | +70 | +2% | 19,500 |
101～
150
件表示中 / 3676件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 410,500円 | +7.1% | -35.0% | 2.92% | 33.94倍 | 0.95倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 359,000円 | +14.5% | -2.3% | 2.51% | 13.13倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 236,700円 | +15.0% | -7.3% | 2.96% | 7.77倍 | 0.73倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 213,300円 | +14.2% | +41.0% | 2.16% | 10.45倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 154,600円 | - | - | 0.00% | - | 71.61倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
